RNA Therapeutics: The Evolving Landscape of Research, Challenges, and Opportunities

ACS Webinars

With the rapid success in the development of lipid-RNA nanoparticles for mRNA vaccines against COVID-19 and the creation of several approved RNA-based drugs, RNA therapeutics have demonstrated enormous potentials for many previously untreatable diseases.

Join a panel of four experts with diversified research background in this field as they share with you their most direct experience in the research and development of RNA therapeutics.

This ACS Webinar is moderated by VP and CSO, Gilles Georges of CAS and co-produced with CAS, a division of the American Chemical Society.

* If you are having technical difficulties viewing the video please try different internet browsers like Chrome, Firefox, and Explorer. If you still can not access the video please review the following computer prerequisites from our video hosting platform.

What You Will Learn

  • Academic, commercial, clinical, and big data perspectives on RNA therapeutics
  • Discussion of the current research advancement and emerging trends in this field
  • Challenges and opportunities impacting future progress


Barbara Ambrose
Senior Information Scientist, CAS

John P. Cooke
Medical Director of the Center for RNA Therapeutics, and Chief Translational Science Officer, Houston Methodist Research Institute

Robert DeLong
Associate Professor, Nanotechnology Innovation Center Kansas State,
Kansas State University

Ramana Doppalapudi
Vice President,
Avidity Biosciences

Gilles Georges
Vice President & Chief Scientific Officer, CAS

Co-Produced With

Related Content